Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Acumen Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Acumen Pharmaceuticals (United States)

Livermore, Californiacompany

99

Works

23,053

Citations

51

h-index

Top Research Topics

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Computational Drug Discovery Methods

Top Researchers

Caleb E. Finch University of Southern California

665 works40,919 citationsh-index: 99

Recent Research

Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer’s disease: a qualitative interview study

Elizabeth Merikle,Carrie Presnall,et al.

20260 citations

Cholinesterase and Neurodegenerative Diseases

Functional Brain Connectivity Studies

Bioinformatics and Genomic Networks

Neuroscience and Neuropharmacology Research

Genetic Associations and Epidemiology

Health Systems, Economic Evaluations, Quality of Life

Cardiac pacing and defibrillation studies

Cardiac Arrhythmias and Treatments

Gene expression and cancer classification

Eric Siemers Acumen Pharmaceuticals (United States)

258 works35,822 citationsh-index: 56

299 works34,962 citationsh-index: 93

William L. Klein Northwestern University

259 works31,916 citationsh-index: 79

Franz Hefti Washington University in St. Louis

421 works31,839 citationsh-index: 90

Hugo Vanderstichele Ghent University

296 works22,453 citationsh-index: 72

Alzheimer's disease Stage 1 and 2: Biology, diagnostics, and treatment

Suzanne E. Schindler,Oskar Hansson,et al.

20260 citations

Amyloid beta oligomers from human Alzheimer’s disease brain isolated by immunoaffinity chromatography

Omar Orlando De Leon,Raghd Nowar,et al.

20250 citations

ALTITUDE‐AD: Cost Savings Using a pTau217 Screening Assay in an Ongoing Phase 2 Study of Sabirnetug in Early Alzheimer's Disease

Todd Feaster,Prajakta Dinesh Mangeshkar,et al.

20250 citations

Differential Vascular and Non‐Vascular Binding Patterns of ACU193 and R‐Lecanemab in APP;hAPOE4 Mouse Brain Sections

Martine Grenon,Erika N. Cline,et al.

20250 citations

Sabirnetug shows superior selectivity for Aβ oligomers over monomer compared to recombinant lecanemab and aducanumab

Erika N. Cline,Elizabeth A. Johnson,et al.

20250 citations